Clinical Trial: A prospective, multicenter, randomized, open-label clinical study evaluating the efficacy and safety of different triple therapy regimens for Helicobacter pylori eradication. (China)

Posted On: 2026-11-10

China, Nov. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A prospective, multicenter, randomized, open-label clinical study evaluating the efficacy and safety of different triple therapy regimens for Helicobacter pylori eradication.'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600136151

Registration Time: 2026/11/06

Type: Interventional study

Primary Sponsor: Fuzhou University Affiliated Provincial Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=349722

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: A prospective, multicenter, randomized, open-label clinical study evaluating the efficacy and safety of different triple therapy regimens for Helicobacter pylori eradication. (China)